Back to Investors
S

S32

Venture Capital

Portfolio

1

companies


Portfolio companies

BR

Basecamp Research

Basecamp Research uses artificial intelligence to explore beyond known biology and solve life science challenges.


Team

AC

Andy Conrad

former CEO of Google’s Verily Life Sciences


Recent investments

Series B
£45.9M

Singular led the Series B round, which will help fund data collection and foundational model development.

"We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem."
— Glen Gowers, co-founder and CEO